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Alopecia areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmune attack 1, 2 . The genetic basis of AA is largely unknown. We undertook a genome-wide association study (GWAS) in a sample of 1,054 cases and 3,278 controls and identified 139 single nucleotide polymorphisms that are significantly associated with AA (P # 5 3 10
27
). Here we show an association with genomic regions containing several genes controlling the activation and proliferation of regulatory T cells (T reg cells), cytotoxic T lymphocyteassociated antigen 4 (CTLA4), interleukin (IL)-2/IL-21, IL-2 receptor A (IL-2RA; CD25) and Eos (also known as Ikaros family zinc finger 4; IKZF4), as well as the human leukocyte antigen (HLA) region. We also find association evidence for regions containing genes expressed in the hair follicle itself (PRDX5 and STX17). A region of strong association resides within the ULBP (cytomegalovirus UL16-binding protein) gene cluster on chromosome 6q25.1, encoding activating ligands of the natural killer cell receptor NKG2D that have not previously been implicated in an autoimmune disease. By probing the role of ULBP3 in disease pathogenesis, we also show that its expression in lesional scalp from patients with AA is markedly upregulated in the hair follicle dermal sheath during active disease. This study provides evidence for the involvement of both innate and acquired immunity in the pathogenesis of AA. We have defined the genetic underpinnings of AA, placing it within the context of shared pathways among autoimmune diseases, and implicating a novel disease mechanism, the upregulation of ULBP ligands, in triggering autoimmunity.
AA affects about 5.3 million people in the United States alone, including males and females across all ethnic groups, with a lifetime risk of 1.7% (refs 1, 2) . Autoimmunity develops against the hair follicle, resulting in non-scarring hair loss that may begin as patches that can coalesce and progress to cover the entire scalp (alopecia totalis) or eventually the entire body (alopecia universalis) (Supplementary Fig. 1 ). The phenomenon of 'sudden whitening of the hair' is ascribed to the acute onset of AA at times of profound grief, stress or fear 3 , in which the pigmented hair is selectively shed while the white hair persists. AA spares the stem cell compartment and attacks only the base of the hair follicle, which is surrounded by infiltrating lymphocytes. Despite these marked perturbations in the hair follicle, there is no permanent organ destruction, and regrowth of the hair remains possible. The concept of an autoimmune mechanism as the basis for AA emerged during the twentieth century from multiple lines of evidence 4 . AA hair follicles are surrounded by an immune infiltrate with activated T-helper cells (T H cells), cytotoxic T cells (T C cells) and natural killer (NK) cells, characterized as a T H 1-type inflammatory response 5, 6 . The notion of a collapse of immune privilege is thought to be a key event in triggering AA 4, 7 . Evidence supporting a genetic basis for AA stems from multiple lines of research, including the observed heritability in first-degree relatives 8, 9 , twin studies 10 and, most recently, from our family-based linkage studies 11 . Although a number of candidate-gene association studies were performed over the past two decades, the informativeness of these studies was inherently limited by small sample sizes and preselection of candidate genes.
To determine the genetic architecture of AA, we genotyped or used publicly available data for up to 1,054 AA cases and 3,278 controls with a combination of Illumina 610K and 550K arrays. We performed association tests adjusted for residual population stratification (l 5 1.051) and found 139 single nucleotide polymorphisms (SNPs) significant at 5 3 10 27 ( Fig. 1 and Supplementary Table 1 ). Our analysis identified several susceptibility loci for AA, most of which clustered into eight genomic regions and fell within discrete linkage disequilibrium (LD) blocks ( Fig. 2 and Table 1 ). These include loci on chromosome 2q33.2 containing CTLA4, chromosome 4q27 containing IL-2/IL-21, chromosome 6p21.32 containing the HLA, chromosome 6q25.1 harbouring the ULBP genes, chromosome 10p15.1 containing IL-2RA (CD25), and chromosome 12q13 containing Eos (IKZF4) and ERBB3. One SNP resides on chromosome 9q31.1 within syntaxin 17 (STX17), and one resides on Results are plotted as negative log-transformed P values from a genotypic association test controlled for residual population stratification as a function of the position in the genome. Odd chromosomes are in green and even chromosomes in blue. Eight genomic regions contain SNPs that exceed the genome-wide significance threshold of 5 3 10 27 (redchromosome 11q13, upstream from peroxiredoxin 5 (PRDX5). Several of these LD blocks coincide with regions of linkage that we reported previously on chromosomes 6p (HLA), 6q (ULBPs), 10p (IL-2RA) and 18p (PTPN2) 11 . We also identified an additional 163 SNPs that were nominally significant (10 24 , P , 5 3 10
), which include 12 regions containing genes involved in the immune response, notably IL-13, IL-6, IL-26, IFNG, SOCS1 and PTPN2 (Supplementary  Tables 2 and 3) . Finally, imputation analysis from HapMap release 2.2 identified additional statistically significant SNPs within each of the eight regions and one additional SNP in PTPN2 that raised it above statistical significance (Supplementary Tables 3 and 4) .
We next assessed the extent to which these genetic risk factors contribute to AA. First, we decreased redundancy in our association evidence by using conditional analysis to determine which SNPs represent independent risk factors within each region ( Supplementary Fig. 2 ), thus identifying a set of 16 risk haplotypes ( Fig. 2 and Supplementary Table 1 ). The distribution of risk haplotypes was significantly different between cases and controls (P 5 1.1 3 10 2107 ) (Fig. 2q, r) . To determine the relative contribution of different alleles to the genetic burden of AA, population-attributable risks were calculated for genotypes of individual SNPs and showed large contributions from individual alleles (ranging from 16 to 69%) (Supplementary Table 5 ). Together with the high concordance in siblings 8, 9 , these findings demonstrate an overwhelming contribution of risk from genetic factors in AA, which awaits confirmation in a validation study.
Our GWAS study in AA implicates a new class of NKG2D ligands in autoimmune disease. The ULBP genes reside in a 180-kilobase MHC class I-related cluster on human chromosome 6q25.1 (Fig. 2g, h ) that arose through duplication of the MHC locus 12 . Each of the ULBP genes has been shown to function as an NKG2D-activating ligand 13, 14 . NKG2D ligands, including MICA/B and ULBPs, are stress-induced molecules that act as danger signals to alert NK, natural killer T, dc T and CD8
1 T lymphocytes through the engagement of the receptor NKG2D 13 . We next considered whether perturbations in the hair follicle microenvironment contribute to the initiation of AA. It has been postulated that NKG2D ligands, if overexpressed in genetically susceptible individuals, can trigger an autoimmune response against the tissue expressing the ligand 15 . To probe this hypothesis in the setting of AA, we examined ULBP3 expression within the hair follicle of unaffected scalp (Fig. 3a, b) and patients with AA (Fig. 3c, d ). Whereas ULBP3 is expressed at low levels within the dermal papilla in normal hair follicle (Fig. 3a, b) , in two different patients with early active AA lesions, we observed marked upregulation of ULBP3 expression in the dermal sheath as well as the dermal papilla (Fig. 3c, d ), but not in control individuals or those with other inflammatory scalp disorders (data not shown). Quantitative immunohistochemistry corroborated a significantly increased number of ULBP3 1 cells in 16 additional AA samples (Fig. 3p) . We also noted a massive inflammatory cell infiltrate characterized by CD8
1

CD3
1 T cells ( Fig. 3g-l ), but only rare NK cells (data not shown). Double immunostaining with an anti-CD8 and an anti-NKG2D antibody revealed that most NKG2D
1 cells were CD8
1
T cells ( Fig. 3m-o) . These results suggest that the autoimmune destruction in AA may be mediated in part by CD8
NKG2D
1 cytotoxic T cells, whose activation may be induced by upregulation of ULBP3 in the dermal sheath of the hair follicle.
The localization of an NK-activating ligand in the outermost layer of the hair follicle places it in an ideal position to express a danger signal 16 and engage NKG2D on immune cells in the local milieu. Inducible overexpression of the ULBP homologues Rae1e and Rae1a in mouse epidermis and pulmonary epithelium were previously shown to markedly alter the immune microenvironment within the skin and lung, respectively 17, 18 . We postulate that in genetically susceptible individuals, upregulation of ULBP3 may have a similar effect on initiating the immune response in AA, and/or may become induced as part of an inflammatory cascade. Consistent with these findings, upregulation of the NK ligand MICA has recently been demonstrated in the hair follicle of patients with AA 19 . Taken together with the increased numbers of perifollicular NKG2D
1
CD8
1 cells that we and others observed in lesional skin of patients with AA ( Fig. 3) 
19
, these data implicate a mechanism involving the expression of NKG2D ligands, including ULBPs, and infiltration of NKG2D-expressing cells in the aetiology of AA.
In addition to ULBP3/ULBP6, we identified other genes that are expressed in the hair follicle and may provide insight into the initiating events ( Supplementary Figs 3 and 4 ). For example, STX17 (rs10760706, P 5 3.60 3 10 27 ) is expressed in the hair follicle 20 and is associated with the grey hair phenotype in horses, which is of interest because AA preferentially attacks pigmented hairs 21 . PRDX5 (rs694739, P 5 4.14 3 10
27
) is an antioxidant enzyme involved in the cellular response to oxidative stress, a process which is dysregulated in AA scalp 22 . PRDX5 has been implicated in the degeneration of target cells in several autoimmune disorders [23] [24] [25] , and other PRDX family members can serve as autoantigens 26 (Supplementary Table 7 ). We found evidence for several genes whose expression in the hair follicle may contribute to a disruption in the local milieu, resulting in the onset of autoimmunity.
Our data implicate several factors that may act together to induce and promote immune dysregulation in the pathogenesis of AA. We found strong evidence for genes involved in the differentiation and 
Typed SNPs that do not reach significance are in grey; significantly associated typed SNPs are in colour, coded by the risk haplotypes. For example in b, conditioning on any of the blue SNPs will decrease evidence for association of the other blue SNPs but will not affect evidence of any of the yellow-coded SNPs. On chromosome 6p in the HLA, significantly associated SNPs can be organized into at least five distinct haplotypes (blue, green, yellow, pink and light blue). The red lines show pairwise LD as measured by r 2 , for the most significant SNP in each haplotype, and define the LD block that is demonstrating association. q, r, The cumulative effect of risk haplotypes is indicated by the distribution of the genetic liability index in cases and controls. We chose the most significantly associated SNP from each haplotype to serve as a proxy for the haplotype, and show in q that the distribution of independent genetic risk factors changes as a function of phenotype, with an average of 13 risk alleles found in controls (grey) and 16 found in cases (red). As the number of risk alleles in an individual increases, the proportion affected by AA increases. The conditional probability of phenotype given count of risk alleles is shown in r (AA in red, control in grey). , as well as a key lineage-determining transcription factor, Foxp3. Foxp3-mediated gene silencing is critical in determining that T reg cells effectively suppress immune responses. Both IL-2 (rs7682241, P 5 4.27 3 10
28
) and its high-affinity receptor IL-2RA (rs3118470, P 5 1.74 3 10
212
) are central in controlling the survival and proliferation of T reg cells. It was recently found that Eos (IKZF4) (rs1701704, P 5 3.21 3 10
28
), a member of the Ikaros family of transcription factors, is a key coregulator of FoxP3-directed gene silencing during T reg differentiation 27 . Although T reg cells probably use several different mechanisms to suppress immune responses, the high expression of CTLA4 (rs1024161, P 5 3.55 3 10
213
) has been proposed as a major determinant of their suppressive activity, particularly because CTLA4 is essential for the inhibitory activity of T reg cells on antigen-presenting cells 28 . The IL-2 locus is tightly linked with IL-21 (rs7682241, P 5 4.27 3 10
28
), which has pleiotropic effects on multiple cell lineages, including CD8 1 T cells, B cells, NK cells and dendritic cells. IL-21 is a major product of proinflammatory T H 17 (IL-17-producing CD4
1 T H cells) and has been shown to have a key role in both promoting the differentiation of T H 17 cells and limiting the differentiation of T reg cells 29 . Collectively, the constellation of immunoregulatory genes implicated in AA clearly point to T reg cells and T H 17 cells as avenues for future studies and novel therapies.
The common-cause hypothesis of autoimmune diseases has received robust validation from GWAS in recent years 30 . This hypothesis evolved initially from epidemiological studies that demonstrated the aggregation of autoimmune diseases within families, and was further supported by findings of shared susceptibility regions in linkage studies.
Our GWAS upheld the previously reported associations of HLA genes in AA and other autoimmune disorders (reviewed in ref. 4 ), whereas we did not find strong evidence for the other loci previously tested in AA using the candidate gene approach (Supplementary Table 6 ). In accordance with the common-cause hypothesis, our GWAS revealed several risk loci in common with other forms of autoimmunity, such as rheumatoid arthritis, type I diabetes, coeliac disease, systemic lupus erythematosus, multiple sclerosis and psoriasis: in particular, CTLA4, IL-2/IL-21, IL-2RA and genes critical to T reg maintenance (Table 1 and  Supplementary Table 1 ). The commonality with rheumatoid arthritis, type I diabetes and coeliac disease is particularly noteworthy in view of the significance of the NKG2D receptor in the pathogenesis of each of these three diseases 15 . Our GWAS establishes the genetic basis of AA, revealing several loci that contribute to disease susceptibility. These findings open new avenues of exploration for therapy based on the underlying mechanisms of AA with a focus not only on T-cell subsets and mechanisms common to other forms of autoimmunity, but also on unique mechanisms that involve signalling pathways downstream of the NKG2D receptor.
METHODS SUMMARY
Cases were ascertained through the National Alopecia Areata Registry (NAAR) with approval from institutional review boards and genotyped on the Illumina HumanHap 610 chip. Three sets of previously published control data sets were used for comparison of allele frequencies. These had been genotyped on the Illumina HumanHap 550v2. All samples were confirmed to be of European ancestry by principal component analysis with ancestry informative markers. Stringent quality control measures were used to remove samples and markers that did not exceed predefined thresholds. Tests of association were run with and without measures to control for residual population stratification. Tissue specimens and RNA from human scalp biopsies were obtained with approval from institutional review boards. All experiments were performed according to the Helsinki guidelines. ; o, merged image. p, Quantification of immunohistochemical staining (positive cells per microscope field at a magnification of 3200) for ULBP3 in 16 patients with AA and in 7 controls showed a significantly increased number of ULBP3 1 cells in the dermis and dermal sheath in patients with AA compared with control skin. In addition, positive cells were also upregulated in perifollicular regions in AA samples, although this was not statistically significant. Data were analysed by Mann-Whitney test for unpaired samples and are expressed as means 6 s.e.m.; asterisk, P , 0.05; two asterisks, P , 0.01.
METHODS
Sample ascertainment. Cases were ascertained through the National Alopecia Areata Registry 31 with approval from institutional review boards. Written informed consent was obtained from all participants. To reduce the possibility of bias resulting from population stratification, only patients who self-reported European ancestry were selected for genotyping. Three sets of previously published control data sets were used for comparison of allele frequencies. These were obtained from the New York Cancer Project 32, 33 and the Cancer Genetic Markers of Susceptibility breast 34 and prostate 35 cancer studies. All cases were genotyped on the Illumina HumanHap 610 chip and all controls were genotyped on the Illumina HumanHap 550v2. All samples were confirmed to be of European ancestry by principal component analysis with ancestry-informative markers. Stringent quality control measures were used to remove samples and markers that did not exceed predefined thresholds. Tests of association were run with and without measures to control for residual population stratification. Tissue specimens and RNA from human scalp biopsies were obtained with approval from institutional review boards. All experiments were performed in accordance with the Helsinki guidelines. Genotyping. Quality control was performed with Helix Tree software (Golden Helix) or PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) 36 . We removed SNPs that lacked more than 5% data, that did not follow Hardy-Weinberg equilibrium in controls (P , 0.0001), that were not present in both Illumina 550Kv2 and Illumina 610K, or that were indicated to have discordant clustering between platforms by Illumina, leaving 463,301 SNPs for analysis. Next, 19 samples with more than 10% missing genotype data were removed. In addition, three case and eight control samples that shared more than 25% inferred identity by descent were removed. Principal component analysis using a subset of 3,568 ancestry informative markers 37 identified 5 cases and 12 controls as ethnic outliers, and these were removed before analysis. Samples more than six standard deviations units from five components were excluded from subsequent analysis. Visual inspection of a plot of the first two eigenvectors identified 141 controls for which matched cases did not exist. These were excluded from further analysis. Statistics. Reported association values were obtained with logistic regression assuming an additive genetic model and included a covariate to adjust for any residual population stratification. Statistics unadjusted for residual population stratification were also examined, as well as P values obtained with the false discovery rate method, and were found to be equivalent to reported values. LD was quantified and evaluated with Haploview 38 . SAS was used to perform stratified analysis and logistic modelling to determine whether SNPs shared a common haplotype. If the adjusted OR differed from the crude estimate by more than 10%, a common haplotype was inferred. Assessment of individual genetic liability was performed in Excel (Microsoft). A single marker was chosen as a proxy for each of the independent risk haplotypes. Alleles for the 16 proxy markers were coded 1 if associated with increased risk and 0 otherwise, and then summed for each individual. A two-tailed Student's t-test was used to determine the significance of the difference in the distribution of risk alleles between cases and controls, under an assumption of unequal variance. The population-attributable fraction (F p ) for each SNP was calculated as
where R i indexes the estimate associated with heterozygous and homozygous carriage of risk-increasing genotypes compared to the normal heterozygote, and F i denotes the genotype frequencies in the controls. LD-based imputation using the Markov Chain Haplotyping algorithm (MACH 1.0.16; http://www.sph.umich. edu/csg/abecasis/mach/tour/imputation.html) was used to perform genome-wide maximum-likelihood genotype imputation. A weighted logistic regression test on binary trait using mach2dat was used to assess the quality of the imputation, again followed by a logistic regression association test assuming an additive model with top ten principal components as covariates to adjust for any residual population stratification using PLINK. Tissue specimens. Human skin scalp biopsies were obtained from 18 patients with AA (age range 28-77 years) from a lesional area; control samples were either biopsies of frontotemporal human skin scalp taken from seven healthy women undergoing facelift surgery (age range 35-67 years) or biopsies from the occipital region of human skin scalp of two healthy men. All experiments were performed in accordance with the Helsinki guidelines. Specimens were embedded directly in OCT compound, or fixed in 10% formalin and embedded in paraffin blocks and cut into sections 5 mm thick.
Immunohistology. To detect ULBP3 protein expression in situ, a staining method based on labelled streptavidin-biotin was performed. In brief, paraffin sections were deparaffinized and immunostained overnight at 4 uC, after antigen retrieval with citrate buffer and using appropriate blocking steps against endogenous peroxidase, with the use of the rabbit anti-human ULBP3 antibody (1:250 dilution in antibody diluent; DCS). All incubation steps were interspersed by washing three times with Tris-buffered saline (10 mM Tris/HCl pH 7.6, 150 mM NaCl) for 5 min each. This was followed by staining with a biotinylated PolyLink secondary antibody (DCS) for 20 min at room temperature, between 20 and 25 uC, and developed for 20 min at room temperature with the peroxidase-streptavidin conjugate (DCS) method. Finally, the slides were labelled with 3-amino-9-ethylcarbazole substrate (Vector Elite ABC Kit; Vector Laboratories) and counterstained with haematoxylin. Quantitative immunohistomorphometry. The number of ULBP3 1 cells was evaluated in three microscopic fields at 2003 magnification in the dermis, in the dermal sheath of the hair follicle and perifollicular around each hair bulb from patients with AA, and in control skin. All data were analysed by a Mann-Whitney test for unpaired samples (results are expressed as means 6 s.e.m.; P , 0.05 was regarded as significant). Indirect immunofluorescence. Indirect immunofluorescence on fresh frozen sections of human scalp skin was performed as described previously 39 . The primary antibodies used were mouse monoclonal anti-ULBP3 (clone 2F9; 1:50 dilution; Santa Cruz Biotechnology), rabbit polyclonal anti-CD3 (1:50; DAKO), mouse monoclonal anti-CD8 (clone C8/144B; prediluted; Abcam), rabbit polyclonal anti-CD8 (1:200; Abcam), mouse monoclonal anti-NKG2D (clone 1D11; 1:100; Abcam), rabbit polyclonal anti-STX17 (1:500; Sigma), rabbit polyclonal anti-PRDX5 (1:500; Abnova), guinea-pig polyclonal anti-K74 (1:2,000), and guinea-pig polyclonal anti-K31 (1:8,000). The anti-K74 and anti-K31 antibodies were provided by L. Langbein. RT-PCR analysis. Total RNA was isolated from scalp skin and whole blood of a healthy control individual by using the RNeasy Minikit (Qiagen) in accordance with the manufacturer's instructions. Total RNA (2 mg) was reverse transcribed with oligo(dT) primers and SuperScript III (Invitrogen). With the use of the firststrand complementary DNAs as templates, PCR was performed with Platinum PCR SuperMix (Invitrogen) and the primer pairs shown in Supplementary Table  8 . The amplification conditions were 94 uC for 2 min, followed by 35 cycles of 94 uC for 30 s, 60 uC for 30 s and 72 uC for 50 s, with a final extension at 72 uC for 7 min. PCR products were run on 2.0% agarose gels. Real-time PCR was performed on an ABI 7300 (Applied Biosystems). PCR reactions were performed with ABI SYBR Green PCR Master Mix, 300 nM primers and 50 ng of cDNA with the following consecutive steps: 50 uC for 2 min, 95 uC for 10 min, and 40 cycles of 95 uC for 15 s and 60 uC for 1 min. The samples were run in triplicate and normalized to an internal control (the glyceraldehyde-3-phosphate dehydrogenase gene) with the accompanying software.
